Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.43 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.43 |
| ▸ | SDHA | P31040 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CALML3 | P27482 | 1/20 | 0.43 |
| ▸ | F10 | P00742 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10063624 | 0.90 | DPP4 (0.42) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL2109049 | 0.90 | DPP4 (0.42) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL2110465 | 0.82 | DPP4 (0.42) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL12342304 | 0.81 | TOP2B (0.51) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL16271842 | 0.80 | DPP4 (0.42) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL29395141 | 0.80 | TOP2B (0.49) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL9890815 | 0.80 | TOP2B (0.49) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL2109002 | 0.80 | TOP2B (0.49) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL28492877 | 0.80 | MAOA (0.47) | MAOAMAOBPTGS1SDHALMNA | |
| SCHEMBL9890813 | 0.80 | DPP4 (0.45) | MAOAMAOBPTGS1SDHALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1620098-B1 | USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS | MORPHOCHEM AG KOMB CHEMIE (DE) | 2008-06-11 | — | — | EP | disclosed |